Crossref
Anticoagulant therapy in eyebrow microblading: Low hemorrhagic risk, underreporting patterns, and the thromboembolic hazards of unsupervised drug withdrawals
Our Dermatology Online · 01.10.2026 · 4 (17)
DOI: 10.7241/ourd.20264.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Our Dermatology Online, online erschienen am 01.10.2026. Verfasst von Airton Barbalho Rodrigues. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rodrigues, A. B. (2026). Anticoagulant therapy in eyebrow microblading: Low hemorrhagic risk, underreporting patterns, and the thromboembolic hazards of unsupervised drug withdrawals. Our Dermatology Online, 4(17). https://doi.org/10.7241/ourd.20264.4
Vancouver
Rodrigues AB. Anticoagulant therapy in eyebrow microblading: Low hemorrhagic risk, underreporting patterns, and the thromboembolic hazards of unsupervised drug withdrawals. Our Dermatology Online. 2026;4(17). doi:10.7241/ourd.20264.4
BibTeX
@article{Rodrigues2026,
author = {Rodrigues, Airton Barbalho},
title = {Anticoagulant therapy in eyebrow microblading: Low hemorrhagic risk, underreporting patterns, and the thromboembolic hazards of unsupervised drug withdrawals},
journal = {Our Dermatology Online},
year = {2026},
volume = {4},
number = {17},
doi = {10.7241/ourd.20264.4}
}
EUVIMED